Assessment of Response to Thienopyridine in Japanese Population (ART-JP)
Not Applicable
- Conditions
- coronary artery disease (CAD)
- Registration Number
- JPRN-UMIN000006336
- Lead Sponsor
- Keio University, School of Medicine, Research Park 5S9
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 300
Inclusion Criteria
Not provided
Exclusion Criteria
1) patients without consent 2) AST > or = 3 x upper limit or ALT > or = 3 x upper 3) Hb < 10 g/dl or platelet < 100k 4) drug allergy to thienopyridine 5) patients with malignancy under treatment or planning to start treatment within one year 6) primary physician thinks it is inappropriate to enroll the patient
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method cardiac death, fatal stroke, non-fatal myocardial infarction, stent thrombosis
- Secondary Outcome Measures
Name Time Method repeat PCI, non cardiovasular death, non-fatal stroke, non-fatal cerebral hemorrhage, bleeding (STEEPLE major or minor), change in bio-marker